ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / November 4, 2024 / Ltd. (NASDAQ:NLSP) ("NLS"), a biopharmaceutical ...

此外，NLS Pharmaceutics宣布与Kadimastem Ltd进行战略合并，使Kadimastem成为NLS的全资子公司。这次合并将促进Kadimastem细胞治疗平台的发展。公司还报告了针对帕金森病的化合物的成功临床前结果，计划开发两种新的后续产品AEX-230和AEX-231用于神经退行性疾病。

NLS Pharmaceutics (NLSP) rose in premarket trading on Monday after the company reported a definitive merger agreement with ...

NLS Pharmaceutics (NLSP) has released an update. NLS Pharmaceutics is undertaking a significant restructuring effort by proposing an ordinary ...

对于NLS Pharmaceutics AG来说，这是充满挑战的一年。该公司股票已触及52周低点，达到4.00美元的价格水平。这一下跌反映了公司市值的显著收缩，一年变化数据显示股价暴跌84.89%。投资者一直密切关注NLSP的表现，因为股票的下行趋势引发了对公司未来前景和在波动市场中整体稳定性的担忧。52周低点作为股票当前状况的关键指标，可能会影响未来几个月投资者的决策。

NLS Pharmaceutics (NLSP) and Kadimastem announced that they have entered into a definitive merger agreement to combine the two companies to ...

Chemistry is at the centre of our existence and offers transformative solutions to many global challenges, including health. RSC Pharmaceutics acknowledges how chemistry and related disciplines can ...

This program accepts the Office of the Vice Provost for Graduate Students and Postdoctoral Scholars basic requirements as described on the English Proficiency Requirements page.

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) shares are moving higher on Monday after the company announced it entered into a ...

Keep learning. Excel in your career. Choose from more than 200 courses in seven different categories, taught by experts in the chemistry community, online and in person.

Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ...